Previous studies conducted in Kenya have continuously to show an increasing trend in HIV drug resistance to NNRTI, NRTI and PIs ( 5 – 7 ) hence the need to revise and introduce new classes of drugs in the treatment program.
← all excerpts
Characterization of HIV-1 Integrase Gene and Resistance Associated Mutations Prior to Roll out of Integrase Inhibitors by Kenyan National HIV-Treatment Program in Kenya.
1
—
—